19 December 2012 10:57 [Source: ICIS news]
LONDON (ICIS)--BASF has extended its offer period to acquire all of the issued and outstanding shares of Norway-based omega-3 fatty acids manufacturer Pronova BioPharma until 18 January 2013, the German chemicals major said on Wednesday. The offer period had been set to end on 19 December.
Based on all outstanding shares and including all net financial liabilities, the enterprise value would be NKr4.85bn, BASF said.
BASF said by 19 December 2012, at 09:00 Central European Time, it had received acceptances under the voluntary offer for a number of shares representing approximately 67.2% of the issued shares and votes in Pronova.
The new 18 January deadline represents the maximum extension of the offer period.
Pronova’s board of directors and its management “unanimously support BASF's offer and recommend its acceptance”, BASF said.
The company expects closing of the offer in the first quarter of 2013, subject to fulfilment of all relevant offer conditions.
($1 = NKr5.60, €1 = NKr7.40)
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
|ICIS Global Petrochemical Index (IPEX). Download the free tabular data and a chart of the historical index|
Asian Chemical Connections